Basel - Roche and its partner Plexxikon have published results from a Phase I study at Massachusetts General Hospital with their selective oral blocker of the oncogenic V600E...

Basel - Roche and its partner Plexxikon have published results from a Phase I study at Massachusetts General Hospital with their selective oral blocker of the oncogenic V600E...

Paris – French public biotech company BioAlliance Pharma SA has announced the launch of Oravig (marketed as

Paris – French public biotech company BioAlliance Pharma SA has announced the launch of Oravig (marketed as

Barcelona – Spanish researchers have analyzed the long-term effects of gut bacterial transplantation in rats, suggesting this approach might be working for inflammatory bowel...

Rome/Sydney – A novel therapy based on Yttrium-90-loaded beads has been shown to be safe and effective in patients with inoperable colorectal cancer liver metastases (British...

Rome/Sydney – A novel therapy based on Yttrium-90-loaded beads has been shown to be safe and effective in patients with inoperable colorectal cancer liver metastases (British...

Lausanne – Cells present in the thymus can be reprogrammed to form skin stem cells without any need for genetic manipulation, according to a research group headed by Yann...

Lausanne – Cells present in the thymus can be reprogrammed to form skin stem cells without any need for genetic manipulation, according to a research group headed by Yann...

Cologne/Carlsbad – Protein expression provider CEVEC Pharmaceuticals has signed a co-exclusive worldwide licensing agreement with Life Technologies Corporation. Under the terms of...